 | • レポートコード：MRC2312MG14917 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、74ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥471,250 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥706,875 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の非侵襲性神経調節デバイス市場規模と予測を収録しています。・世界の非侵襲性神経調節デバイス市場：売上、2018年-2023年、2024年-2029年 ・世界の非侵襲性神経調節デバイス市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の非侵襲性神経調節デバイス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経皮的眼窩上神経刺激」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 非侵襲性神経調節デバイスのグローバル主要企業は、Neuroelectrics、 Aneuvo、 Soterix Medical、 Magstim、 BrainsWay、 ElectroCore Medical、 NeuroCare Group、 Koninklijke Philips、 NESA World、 DEYMED Diagnostic、 electroCore、 Medistar、 Vagustimなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、非侵襲性神経調節デバイスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の非侵襲性神経調節デバイス市場：タイプ別、2018年-2023年、2024年-2029年 世界の非侵襲性神経調節デバイス市場：タイプ別市場シェア、2022年 ・経皮的眼窩上神経刺激、シングルパルス経頭蓋磁気刺激、非侵襲的迷走神経刺激、その他 世界の非侵襲性神経調節デバイス市場：用途別、2018年-2023年、2024年-2029年 世界の非侵襲性神経調節デバイス市場：用途別市場シェア、2022年 ・病院＆クリニック、認知症ケアセンター、研究機関、その他 世界の非侵襲性神経調節デバイス市場：地域・国別、2018年-2023年、2024年-2029年 世界の非侵襲性神経調節デバイス市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における非侵襲性神経調節デバイスのグローバル売上、2018年-2023年 ・主要企業における非侵襲性神経調節デバイスのグローバル売上シェア、2022年 ・主要企業における非侵襲性神経調節デバイスのグローバル販売量、2018年-2023年 ・主要企業における非侵襲性神経調節デバイスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Neuroelectrics、 Aneuvo、 Soterix Medical、 Magstim、 BrainsWay、 ElectroCore Medical、 NeuroCare Group、 Koninklijke Philips、 NESA World、 DEYMED Diagnostic、 electroCore、 Medistar、 Vagustim ************************************************************* ・調査・分析レポートの概要 非侵襲性神経調節デバイス市場の定義 市場セグメント 世界の非侵襲性神経調節デバイス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の非侵襲性神経調節デバイス市場規模 世界の非侵襲性神経調節デバイス市場規模：2022年 VS 2029年 世界の非侵襲性神経調節デバイス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの非侵襲性神経調節デバイスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の非侵襲性神経調節デバイス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：経皮的眼窩上神経刺激、シングルパルス経頭蓋磁気刺激、非侵襲的迷走神経刺激、その他 非侵襲性神経調節デバイスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院＆クリニック、認知症ケアセンター、研究機関、その他 非侵襲性神経調節デバイスの用途別グローバル売上・予測 ・地域別市場分析 地域別非侵襲性神経調節デバイス市場規模 2022年と2029年 地域別非侵襲性神経調節デバイス売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Neuroelectrics、 Aneuvo、 Soterix Medical、 Magstim、 BrainsWay、 ElectroCore Medical、 NeuroCare Group、 Koninklijke Philips、 NESA World、 DEYMED Diagnostic、 electroCore、 Medistar、 Vagustim ... |
This research report provides a comprehensive analysis of the Non-Invasive Neuromodulatory Devices market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Non-Invasive Neuromodulatory Devices market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Non-Invasive Neuromodulatory Devices, challenges faced by the industry, and potential opportunities for market players.
The global Non-Invasive Neuromodulatory Devices market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Non-Invasive Neuromodulatory Devices market presents opportunities for various stakeholders, including Hospitals & Clinics, Cognitive Care Centers. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Non-Invasive Neuromodulatory Devices market. Additionally, the growing consumer demand present avenues for market expansion.
The global Non-Invasive Neuromodulatory Devices market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Non-Invasive Neuromodulatory Devices market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Non-Invasive Neuromodulatory Devices market.
Market Overview: The report provides a comprehensive overview of the Non-Invasive Neuromodulatory Devices market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Transcutaneous Supraorbital Neurostimulation, Single-Pulse Transcranial Magnetic Stimulation), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Non-Invasive Neuromodulatory Devices market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Non-Invasive Neuromodulatory Devices market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Non-Invasive Neuromodulatory Devices market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Non-Invasive Neuromodulatory Devices market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Non-Invasive Neuromodulatory Devices market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Non-Invasive Neuromodulatory Devices market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Non-Invasive Neuromodulatory Devices, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Non-Invasive Neuromodulatory Devices market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Non-Invasive Neuromodulatory Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Transcutaneous Supraorbital Neurostimulation
Single-Pulse Transcranial Magnetic Stimulation
Non-invasive Vagal Nerve Stimulation
Others
Market segment by Application
Hospitals & Clinics
Cognitive Care Centers
Research Institutes
Others
Global Non-Invasive Neuromodulatory Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Neuroelectrics
Aneuvo
Soterix Medical
Magstim
BrainsWay
ElectroCore Medical
NeuroCare Group
Koninklijke Philips
NESA World
DEYMED Diagnostic
electroCore
Medistar
Vagustim
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Invasive Neuromodulatory Devices, market overview.
Chapter 2: Global Non-Invasive Neuromodulatory Devices market size in revenue and volume.
Chapter 3: Detailed analysis of Non-Invasive Neuromodulatory Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Invasive Neuromodulatory Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-Invasive Neuromodulatory Devices capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Non-Invasive Neuromodulatory Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Invasive Neuromodulatory Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Invasive Neuromodulatory Devices Overall Market Size
2.1 Global Non-Invasive Neuromodulatory Devices Market Size: 2022 VS 2029
2.2 Global Non-Invasive Neuromodulatory Devices Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-Invasive Neuromodulatory Devices Sales: 2018-2029
3 Company Landscape
3.1 Top Non-Invasive Neuromodulatory Devices Players in Global Market
3.2 Top Global Non-Invasive Neuromodulatory Devices Companies Ranked by Revenue
3.3 Global Non-Invasive Neuromodulatory Devices Revenue by Companies
3.4 Global Non-Invasive Neuromodulatory Devices Sales by Companies
3.5 Global Non-Invasive Neuromodulatory Devices Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-Invasive Neuromodulatory Devices Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-Invasive Neuromodulatory Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-Invasive Neuromodulatory Devices Players in Global Market
3.8.1 List of Global Tier 1 Non-Invasive Neuromodulatory Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-Invasive Neuromodulatory Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Non-Invasive Neuromodulatory Devices Market Size Markets, 2022 & 2029
4.1.2 Transcutaneous Supraorbital Neurostimulation
4.1.3 Single-Pulse Transcranial Magnetic Stimulation
4.1.4 Non-invasive Vagal Nerve Stimulation
4.1.5 Others
4.2 By Type – Global Non-Invasive Neuromodulatory Devices Revenue & Forecasts
4.2.1 By Type – Global Non-Invasive Neuromodulatory Devices Revenue, 2018-2023
4.2.2 By Type – Global Non-Invasive Neuromodulatory Devices Revenue, 2024-2029
4.2.3 By Type – Global Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
4.3 By Type – Global Non-Invasive Neuromodulatory Devices Sales & Forecasts
4.3.1 By Type – Global Non-Invasive Neuromodulatory Devices Sales, 2018-2023
4.3.2 By Type – Global Non-Invasive Neuromodulatory Devices Sales, 2024-2029
4.3.3 By Type – Global Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
4.4 By Type – Global Non-Invasive Neuromodulatory Devices Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Non-Invasive Neuromodulatory Devices Market Size, 2022 & 2029
5.1.2 Hospitals & Clinics
5.1.3 Cognitive Care Centers
5.1.4 Research Institutes
5.1.5 Others
5.2 By Application – Global Non-Invasive Neuromodulatory Devices Revenue & Forecasts
5.2.1 By Application – Global Non-Invasive Neuromodulatory Devices Revenue, 2018-2023
5.2.2 By Application – Global Non-Invasive Neuromodulatory Devices Revenue, 2024-2029
5.2.3 By Application – Global Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
5.3 By Application – Global Non-Invasive Neuromodulatory Devices Sales & Forecasts
5.3.1 By Application – Global Non-Invasive Neuromodulatory Devices Sales, 2018-2023
5.3.2 By Application – Global Non-Invasive Neuromodulatory Devices Sales, 2024-2029
5.3.3 By Application – Global Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
5.4 By Application – Global Non-Invasive Neuromodulatory Devices Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Non-Invasive Neuromodulatory Devices Market Size, 2022 & 2029
6.2 By Region – Global Non-Invasive Neuromodulatory Devices Revenue & Forecasts
6.2.1 By Region – Global Non-Invasive Neuromodulatory Devices Revenue, 2018-2023
6.2.2 By Region – Global Non-Invasive Neuromodulatory Devices Revenue, 2024-2029
6.2.3 By Region – Global Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
6.3 By Region – Global Non-Invasive Neuromodulatory Devices Sales & Forecasts
6.3.1 By Region – Global Non-Invasive Neuromodulatory Devices Sales, 2018-2023
6.3.2 By Region – Global Non-Invasive Neuromodulatory Devices Sales, 2024-2029
6.3.3 By Region – Global Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Non-Invasive Neuromodulatory Devices Revenue, 2018-2029
6.4.2 By Country – North America Non-Invasive Neuromodulatory Devices Sales, 2018-2029
6.4.3 US Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.4.4 Canada Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.4.5 Mexico Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Non-Invasive Neuromodulatory Devices Revenue, 2018-2029
6.5.2 By Country – Europe Non-Invasive Neuromodulatory Devices Sales, 2018-2029
6.5.3 Germany Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.4 France Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.5 U.K. Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.6 Italy Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.7 Russia Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.8 Nordic Countries Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.9 Benelux Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Non-Invasive Neuromodulatory Devices Revenue, 2018-2029
6.6.2 By Region – Asia Non-Invasive Neuromodulatory Devices Sales, 2018-2029
6.6.3 China Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.6.4 Japan Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.6.5 South Korea Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.6.6 Southeast Asia Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.6.7 India Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Non-Invasive Neuromodulatory Devices Revenue, 2018-2029
6.7.2 By Country – South America Non-Invasive Neuromodulatory Devices Sales, 2018-2029
6.7.3 Brazil Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.7.4 Argentina Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Non-Invasive Neuromodulatory Devices Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Non-Invasive Neuromodulatory Devices Sales, 2018-2029
6.8.3 Turkey Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.8.4 Israel Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.8.5 Saudi Arabia Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.8.6 UAE Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Neuroelectrics
7.1.1 Neuroelectrics Company Summary
7.1.2 Neuroelectrics Business Overview
7.1.3 Neuroelectrics Non-Invasive Neuromodulatory Devices Major Product Offerings
7.1.4 Neuroelectrics Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.1.5 Neuroelectrics Key News & Latest Developments
7.2 Aneuvo
7.2.1 Aneuvo Company Summary
7.2.2 Aneuvo Business Overview
7.2.3 Aneuvo Non-Invasive Neuromodulatory Devices Major Product Offerings
7.2.4 Aneuvo Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.2.5 Aneuvo Key News & Latest Developments
7.3 Soterix Medical
7.3.1 Soterix Medical Company Summary
7.3.2 Soterix Medical Business Overview
7.3.3 Soterix Medical Non-Invasive Neuromodulatory Devices Major Product Offerings
7.3.4 Soterix Medical Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.3.5 Soterix Medical Key News & Latest Developments
7.4 Magstim
7.4.1 Magstim Company Summary
7.4.2 Magstim Business Overview
7.4.3 Magstim Non-Invasive Neuromodulatory Devices Major Product Offerings
7.4.4 Magstim Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.4.5 Magstim Key News & Latest Developments
7.5 BrainsWay
7.5.1 BrainsWay Company Summary
7.5.2 BrainsWay Business Overview
7.5.3 BrainsWay Non-Invasive Neuromodulatory Devices Major Product Offerings
7.5.4 BrainsWay Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.5.5 BrainsWay Key News & Latest Developments
7.6 ElectroCore Medical
7.6.1 ElectroCore Medical Company Summary
7.6.2 ElectroCore Medical Business Overview
7.6.3 ElectroCore Medical Non-Invasive Neuromodulatory Devices Major Product Offerings
7.6.4 ElectroCore Medical Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.6.5 ElectroCore Medical Key News & Latest Developments
7.7 NeuroCare Group
7.7.1 NeuroCare Group Company Summary
7.7.2 NeuroCare Group Business Overview
7.7.3 NeuroCare Group Non-Invasive Neuromodulatory Devices Major Product Offerings
7.7.4 NeuroCare Group Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.7.5 NeuroCare Group Key News & Latest Developments
7.8 Koninklijke Philips
7.8.1 Koninklijke Philips Company Summary
7.8.2 Koninklijke Philips Business Overview
7.8.3 Koninklijke Philips Non-Invasive Neuromodulatory Devices Major Product Offerings
7.8.4 Koninklijke Philips Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.8.5 Koninklijke Philips Key News & Latest Developments
7.9 NESA World
7.9.1 NESA World Company Summary
7.9.2 NESA World Business Overview
7.9.3 NESA World Non-Invasive Neuromodulatory Devices Major Product Offerings
7.9.4 NESA World Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.9.5 NESA World Key News & Latest Developments
7.10 DEYMED Diagnostic
7.10.1 DEYMED Diagnostic Company Summary
7.10.2 DEYMED Diagnostic Business Overview
7.10.3 DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Major Product Offerings
7.10.4 DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.10.5 DEYMED Diagnostic Key News & Latest Developments
7.11 electroCore
7.11.1 electroCore Company Summary
7.11.2 electroCore Business Overview
7.11.3 electroCore Non-Invasive Neuromodulatory Devices Major Product Offerings
7.11.4 electroCore Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.11.5 electroCore Key News & Latest Developments
7.12 Medistar
7.12.1 Medistar Company Summary
7.12.2 Medistar Business Overview
7.12.3 Medistar Non-Invasive Neuromodulatory Devices Major Product Offerings
7.12.4 Medistar Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.12.5 Medistar Key News & Latest Developments
7.13 Vagustim
7.13.1 Vagustim Company Summary
7.13.2 Vagustim Business Overview
7.13.3 Vagustim Non-Invasive Neuromodulatory Devices Major Product Offerings
7.13.4 Vagustim Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.13.5 Vagustim Key News & Latest Developments
8 Global Non-Invasive Neuromodulatory Devices Production Capacity, Analysis
8.1 Global Non-Invasive Neuromodulatory Devices Production Capacity, 2018-2029
8.2 Non-Invasive Neuromodulatory Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-Invasive Neuromodulatory Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-Invasive Neuromodulatory Devices Supply Chain Analysis
10.1 Non-Invasive Neuromodulatory Devices Industry Value Chain
10.2 Non-Invasive Neuromodulatory Devices Upstream Market
10.3 Non-Invasive Neuromodulatory Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-Invasive Neuromodulatory Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer